Urologia JournalPub Date : 2025-07-10DOI: 10.1177/03915603251351767
María E Garza-Montúfar, Hid F Cordero-Franco, Carlos M García-Pérez, Juan H Díaz-García, Brissia Lazalde
{"title":"An Effective Classification System for the Treatment of Encrusted Ureteral Stents.","authors":"María E Garza-Montúfar, Hid F Cordero-Franco, Carlos M García-Pérez, Juan H Díaz-García, Brissia Lazalde","doi":"10.1177/03915603251351767","DOIUrl":"https://doi.org/10.1177/03915603251351767","url":null,"abstract":"<p><strong>Background: </strong>We created a classification system for encrusted ureteral stents (ES) (<b>G</b>rading system for <b>A</b>dditional lithiasis and u<b>R</b>eteral <b>S</b>tent c<b>A</b>lcification -GARSA-, I-III grades), we demonstrate its utility for predicting the surgical outcome and the need of complex surgery.</p><p><strong>Methods: </strong>Retrospective review of patients with ES; clinico-demographics, additional lithiasis (AL), stent calcification characteristics, surgeries performed, complications and stone free rate were collected. Chi-square was used to compare the categorical variables and Kruskal-Wallis test for the comparison > 2 numerical groups; a <i>p</i>-value < .05 was considered significant.</p><p><strong>Results: </strong>We included 190 ES; 163 (85.8%) stents underwent one-time surgical removal. Most Grade I catheters were removed in a single surgery, without invasive/multimodal therapy; Grade II-III catheters required multimodal and invasive therapies. The presence of AL in kidney increased the number of surgical interventions performed in Grade I/II catheters (<i>p</i> < 0.05) and the likelihood of requiring multimodal (Grade I: 90%, Grade II: 83.3%, Grade III: 100%) or invasive surgery (Grade I: 38.1%, Grade II 58.3%, Grade III 90.9%) to achieve successful treatment.</p><p><strong>Conclusions: </strong>Incorporating both the calcified stent characteristics and the presence of AL, GARSA score can be used to determine the selection of the optimal surgical approach for patients with encrusted stents.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"3915603251351767"},"PeriodicalIF":0.8,"publicationDate":"2025-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144601720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Urologia JournalPub Date : 2025-07-07DOI: 10.1177/03915603251351069
Hossam Mohamed Hafez Elawady, Wael Ali Maged, Mostafa Mabrouk Bayoumi Aly Wahba, Ahmed Tawfick Hassan, Mahmoud Ahmed Mahmoud
{"title":"Modalities of management of residual upper calyceal stones after percutaneous nephrolithotomy for staghorn stone: A randomized controlled trial.","authors":"Hossam Mohamed Hafez Elawady, Wael Ali Maged, Mostafa Mabrouk Bayoumi Aly Wahba, Ahmed Tawfick Hassan, Mahmoud Ahmed Mahmoud","doi":"10.1177/03915603251351069","DOIUrl":"https://doi.org/10.1177/03915603251351069","url":null,"abstract":"<p><strong>Background: </strong>This study assessed the safety and efficacy of management strategies for residual upper calyceal stones (1-2 cm) following percutaneous nephrolithotomy for staghorn calculi, comparing conservative management to interventional approaches.</p><p><strong>Methods: </strong>A randomized trial included 105 patients with residual stones, assigned to flexible ureterorenoscopic laser lithotripsy (Group A), extracorporeal shock wave lithotripsy (ESWL, Group B), or conservative management (Group C). Outcomes included the need for additional interventions, stone-free rates, complications, and cost-effectiveness. Patients were followed for 1 year to assess pain, hematuria, hospital readmission, and stone clearance.</p><p><strong>Results: </strong>Conservative management led to a 20% intervention rate within a year, primarily due to pain, obstruction, or patient preference. A stone size ⩽ 1.4 cm predicted the likelihood of intervention. Flexible ureterorenoscopy had the highest stone-free rate (94.29%), followed by ESWL (71.43%, <i>p</i> = 0.023). ESWL was the most cost-effective option (10.17 × 10³ vs 39.47 × 10³ Egyptian pounds, <i>p</i> < 0.001) but was less effective for high-density stones.</p><p><strong>Conclusions: </strong>While conservative management avoids immediate intervention, it carries a higher risk of future complications and delayed interventions. Early intervention with flexible ureterorenoscopy or ESWL offers better long-term outcomes, with ESWL being the most cost-effective option.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"3915603251351069"},"PeriodicalIF":0.8,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144576415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Mini-PCNL (percutaneous nephrolithotomy) versus FURSL (flexible ureteroscopy and laser lithotripsy): A head-to-head comparison in treating calyceal diverticulum stones: A prospective randomized study.","authors":"Haitham Abdalla Shello, Mahmoud Gabril, Rehab Kamal Mahmoud, Abdelaziz Elhendawy, Omar Abdelaal","doi":"10.1177/03915603251344500","DOIUrl":"https://doi.org/10.1177/03915603251344500","url":null,"abstract":"<p><strong>Purpose: </strong>To compare the efficacy and safety of mini-percutaneous nephrolithotomy versus flexible ureteroscopy with laser lithotripsy in the management of calyceal diverticulum stones.</p><p><strong>Methods: </strong>The study performed a prospective analysis of 91 patients with confirmed calyceal diverticulum stones in Saudi Arabia from January 2020 to June 2024. A total of 78 patients with CD (calyceal diverticulum) stones were randomly divided into two groups: Group A (<i>n</i> = 39) FURSL and Group B (<i>n</i> = 39) mini-PCNL. The study analyzed patient demographics, stone complexity, operative parameters, postoperative results, and postoperative outcomes, including stone-free rates, operative time, hospital stay, complication rates, and recovery time.</p><p><strong>Results: </strong>Both groups showed similar baseline characteristics and surgical feasibility, with the mini-PCNL group showing a higher SFR (84.62% vs 71.79%), but not statistically significant. Hospital stay was significantly shorter in the FURSL group (17.31 ± 3.06 h vs 30.03 ± 7.18 h; <i>p</i> < 0.001). Patients undergoing FURSL returned to normal activity sooner (5.1 ± 1.37 days vs 8.03 ± 1.05 days; <i>p</i> < 0.05). Complication rates were low and nearly similar across groups.</p><p><strong>Conclusions: </strong>Both mini-PCNL and FURSL are effective strategies for treating calyceal diverticulum stones. Notably, mini-PCNL offers superior stone-free rates, while FURSL offers shorter operative times, hospital stays, and fast recovery.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"3915603251344500"},"PeriodicalIF":0.8,"publicationDate":"2025-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144561315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Urologia JournalPub Date : 2025-06-27DOI: 10.1177/03915603251347441
Kamil Malshy, Zijing Cheng, Trevor C Hunt, Timothy D Campbell, Matthew Steidle, Jason Fairbourn, Ashley Li, Victor Kucherov, Jathin Bandari
{"title":"The impact of pelvic radiotherapy on hematological toxicities in pediatric genitourinary rhabdomyosarcoma.","authors":"Kamil Malshy, Zijing Cheng, Trevor C Hunt, Timothy D Campbell, Matthew Steidle, Jason Fairbourn, Ashley Li, Victor Kucherov, Jathin Bandari","doi":"10.1177/03915603251347441","DOIUrl":"https://doi.org/10.1177/03915603251347441","url":null,"abstract":"<p><strong>Objectives: </strong>Hematological toxicities are a common sequelae of radiation therapy (RT), and pelvic RT is of particular concern as the pelvic marrow contributes nearly 50% of total body hematopoiesis. We evaluated the impact of pelvic RT on hematological toxicities in pediatric patients with pelvic genitourinary rhabdomyosarcoma (GU-RMS).</p><p><strong>Methods: </strong>A secondary evaluation of 448 pediatric patients (53.8% male) with intermediate-risk RMS in the ARST0531 trial included 65 with pelvic GU-RMS (who received pelvic RT). Multivariable logistic regression was used to compare cytopenias and complications (febrile neutropenia, infectious complications) between GU-RMS and non-GU-RMS. Primary analysis assessed toxicities over the study period (weeks 1-43), with secondary analysis evaluating T1 (weeks 1-15), T2 (weeks 16-30), and T3 (weeks 31-43).</p><p><strong>Results: </strong>GU-RMS patients did not have a significantly higher risk of cytopenias than non-GU RMS patients. Neutropenia was the most common, affecting 79.4% of subjects, with no significant difference between the GU (73.8%) and non-GU (80.4%) groups (OR 0.64, 95% CI 0.34-1.19, <i>p</i> = 0.16). Anemia rates were similar in the GU (36.9%; <i>n</i> = 24) and non-GU (35.2%; <i>n</i> = 135) groups (OR 0.96, 95% CI 0.54-1.70, <i>p</i> = 0.89). Thrombocytopenia occurred slightly more often in the GU group (33.8%) than the non-GU group (28.4%) but was not statistically significant (OR 1.49, 95% CI 0.81-2.73, <i>p</i> = 0.20). Pelvic RT for GU-RMS in T1 was linked to a significantly higher risk of thrombocytopenia compared to non-GU subjects (OR 2.79, 95% CI 1.25-6.23, p = 0.01), which declined over time (T2, T3). Rates of febrile neutropenia (3.1%-9.2%) and infectious complications (4.6%-15.4%) in GU patients did not differ significantly from those in non-GU cohorts (febrile neutropenia: 7.3%-13.05%; infectious complications: 5.5%-9.7%) across T1-T3.</p><p><strong>Conclusions: </strong>Hematological toxicities were comparable between pediatric GU and non-GU RMS patients. Pelvic RT for GU-RMS increased the risk of early thrombocytopenia, which diminished over time.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"3915603251347441"},"PeriodicalIF":0.8,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144508465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Comparison of long-term survival for muscle-invasive bladder cancer patients who underwent bladder preservation therapy and radical cystectomy: A systematic review and meta-analysis.","authors":"Syah Mirsya Warli, Bungaran Sihombing, Dhirajaya Dharma Kadar, Ginanda Putra Siregar, Fauriski Febrian Prapiska, Lidya Imelda Laksmi, Bayu Hernawan Rahmat Muharia","doi":"10.1177/03915603251347444","DOIUrl":"https://doi.org/10.1177/03915603251347444","url":null,"abstract":"<p><strong>Objective/purpose: </strong>This study aims to compare BPT and RC for long-term survival and quality of life outcomes in MIBC patients.</p><p><strong>Materials and methods: </strong>The study conducted based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020, with search strategy across databases (PubMed, Scopus, Cochrane Library, EMBASE, and MEDLINE) used relevant keywords. RCTs, observational studies, and simulation studies were included. Each included study was evaluated with the Newcastle-Ottawa Scale (NOS) for observational studies and the Jadad score for randomized controlled trials (RCTs). Disagreements between reviewers were resolved by consensus, and inter-rater agreement was assessed using Cohen's Kappa statistic. The meta-analysis was performed with Review Manager (RevMan), v5.4.</p><p><strong>Results: </strong>Seven studies (six retrospective cohorts, one RCT) met the inclusion criteria with a total of 25,212 patients. Analysis of four studies evaluating the comparison of BPT and RC showed no statistically significant differences in overall survival rates between the two therapies (HR = 1.14, 95%CI: 0.99-1.31, <i>p</i> = 0.07, <i>I</i><sup>2</sup> = 0%). Subgroup analysis results showed significant differences in overall mortality (HR = 1.16, 95%CI: 0.94-1.42, <i>p</i> = 0.17, <i>I</i><sup>2</sup> = 9%) and bladder cancer-specific mortality (HR = 1.11, 95%CI: 0.89-1.39, <i>p</i> = 0.34, <i>I</i><sup>2</sup> = 0%) between the two treatment approaches.</p><p><strong>Conclusion: </strong>Compared to RC, BPT generally demonstrated similar results in terms of survival, local recurrence-free survival, and disease-free survival. Treatment decisions should be individualized, considering patient preferences, tumor characteristics, and available resources.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"3915603251347444"},"PeriodicalIF":0.8,"publicationDate":"2025-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144508463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Urologia JournalPub Date : 2025-06-26DOI: 10.1177/03915603251347448
Murad Asali, Osman Hallak, Galeb Asali
{"title":"Do flexible ureteroscopies affect renal function?","authors":"Murad Asali, Osman Hallak, Galeb Asali","doi":"10.1177/03915603251347448","DOIUrl":"https://doi.org/10.1177/03915603251347448","url":null,"abstract":"<p><strong>Objective: </strong>To determine whether flexible ureteroscopies (f-URS) affect renal function by performing dynamic renal scans (DTPA or MAG3) pre- and post-operatively.</p><p><strong>Patients and methods: </strong>Between April 2010 and March 2024, 945 renal units underwent ureterorenoscopy, of which 101 renal units with upper urinary tract stones (UUTS) completed a renal scan, either DTPA or MAG3 pre- and post-f-URS. The cases were divided into three groups: worsened (>10%), improved (>10%), or unaffected (stable) renal function (⩽10% change). Patient demographics, imaging data, stone properties, and treatment outcomes were comprehensively evaluated. The evaluation of postoperative complications was performed using the Clavien-Dindo classification.</p><p><strong>Results: </strong>The mean patient age was 53.4 years. The mean stone size was 11.4 mm. Renal pelvis, upper, and middle calyces, and lower pole stones were found in 12.9% (13), 28.7% (29), and 34.7% (35) of cases, respectively. Single- and second-session SFRs were 95% and 99%, respectively. A third auxiliary procedure was needed in one renal unit (1%). The mean number of procedures per renal unit was 1.06 (107/101). The mean renal function pre and post-operatively was 47.3% and 48%, respectively. The majority of patients (94.1%) had unchanged renal function. However, three female patients (3%) had a decline in differential renal function (>10%) while three patients (two males and one female) (3%) had an improvement (>10%). A re-intervention was necessary in one patient, interestingly not among those with declined renal function.</p><p><strong>Conclusions: </strong>Flexible ureteroscopy due to renal or ureteral stones has minimal to no impact on renal function. Renal scans pre- and post-operatively may be used in potentially high-risk patients.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"3915603251347448"},"PeriodicalIF":0.8,"publicationDate":"2025-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144508464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Urologia JournalPub Date : 2025-06-20DOI: 10.1177/03915603251345029
Koji Amano, Kumi Suzuki
{"title":"Factors associated with quality of life in post-prostatectomy patients with cancer who experience lower urinary tract symptoms: A cross-sectional study.","authors":"Koji Amano, Kumi Suzuki","doi":"10.1177/03915603251345029","DOIUrl":"10.1177/03915603251345029","url":null,"abstract":"<p><strong>Background: </strong>Radical prostatectomy is the standard of care for prostate cancer. Identification of the association between post-operative lower urinary tract symptoms and quality of life (QOL) is critical for enhancing patient self-management.</p><p><strong>Aims: </strong>This study identified the factors associated with the QOL of patients with cancer post-prostatectomy.</p><p><strong>Methods: </strong>Participants were patients with lower urinary tract symptoms who had undergone prostatectomy at one of four institutions and had completed the QOL questionnaire. Descriptive statistics and correlations were obtained, and multiple regression analyses were conducted with QOL as the dependent variable.</p><p><strong>Results: </strong>Except for \"personal relationships,\" the eight sub-domains of QOL in the King's Health Questionnaire were significantly positively correlated with International Prostate Symptom Score (IPSS) and International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) scores. The ICIQ-SF was a predictor of all QOL sub-domains. Marital status and IPSS were associated with \"general health perception,\" \"role limitations\" were associated with post-operative radiation therapy and cohabitation status, \"emotions\" were associated with frequent urination/incontinence medication use, and \"sleep/energy\" was associated with IPSS and post-operative hormone therapy.</p><p><strong>Conclusions: </strong>Providing anticipatory information to at-risk patients before treatment may reduce post-operative life disturbances. Healthcare providers should ensure seamless coordination and promptly collaborate with specialists post-discharge.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"3915603251345029"},"PeriodicalIF":0.8,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144333994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Urologia JournalPub Date : 2025-05-24DOI: 10.1177/03915603251344448
Lucio Dell'Atti, Viktoria Slyusar
{"title":"Daily phosphodiesterase type 5 inhibitors plus acetylsalicylic acid improve curvature progression and pain intensity during the active phase of peyronie's disease.","authors":"Lucio Dell'Atti, Viktoria Slyusar","doi":"10.1177/03915603251344448","DOIUrl":"https://doi.org/10.1177/03915603251344448","url":null,"abstract":"<p><p>The purpose of this study is that the combination effects of Peyronie's disease (PD) therapy with Phosphodiesterase type 5 inhibitors (PDE5i) plus acetylsalicylic acid on improve curvature progression and pain in the active phase of disease. We performed a retrospective cohort study of 161 patients affected by PD in active stage and erectile dysfunction treated with tadalafil 5 mg once daily were divided in two groups. Group A(GA): 93 men treated with only PDE5i (tadalafil 5 mg) for 1 year or more and Group B(GB): 68 men that received tadalafil 5 mg plus aspirin 100 mg with the same protocol of GA. The patients of both groups were assessed at baseline and follow-up (6 months) for erectile function, painful erections, penile plaque size, and penile curvature. Six months after the treatment the patients in both groups had a non-significantly reduction of penile plaques. However, in GB patients had a clinically significant reduction of the curvature after 6 months by treatments 20.21° ± 7.20 versus 28.13° ± 8.11 (GA), (<i>p</i> < 0.001). In the analysis of our secondary endpoint, we demonstrated a significantly lower intensity of pain during erection in GB (1.43 ± 1.12) compared GA (1.89 ± 1.25; <i>p</i> < 0.001). We observed that the regular use of this therapeutic combination significantly provided more benefit in patients with active stage PD in terms of penile deformity, pain, and discomfort during penetrative intercourses.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"3915603251344448"},"PeriodicalIF":0.8,"publicationDate":"2025-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144143673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Urologia JournalPub Date : 2025-05-24DOI: 10.1177/03915603251341399
Jorge Panach-Navarrete, Lorena Valls-González, Marcos Antonio Lloret-Durà, Lucas Diéguez-Álvarez, José María Martínez-Jabaloyas
{"title":"Use of the Allium stent for management of ureteral pathology: A real-world clinical practice study.","authors":"Jorge Panach-Navarrete, Lorena Valls-González, Marcos Antonio Lloret-Durà, Lucas Diéguez-Álvarez, José María Martínez-Jabaloyas","doi":"10.1177/03915603251341399","DOIUrl":"https://doi.org/10.1177/03915603251341399","url":null,"abstract":"<p><strong>Introduction: </strong>The objective of the present study was to carry out a real-world clinical practice study, verifying through prospective analysis whether the Allium stent could resolve different types of ureteral pathologies, with strictures of different etiology and cases of urine leakage.</p><p><strong>Material and methods: </strong>Prospective observational study collecting all cases of Allium ureteral stent placement in our center between 2021 and 2022. Descriptive and comparative analyses were carried out to verify the success rate of Allium stents and pinpoint patient profiles in whom stent implantation would provide effective resolution of stricture or leakage.</p><p><strong>Results: </strong>A total of 30 Allium stent cases were collected in 30 patients, 10 of which were considered successful procedures (eight cases of stricture and two leakage) while 20 were classed as failures (15 stricture and five ureterointestinal urine leakage). The most frequent pathology was ureterointestinal stricture (33.3%) in patients with an ileal conduit, followed by retroperitoneal fibrosis (26.7%) and ureterointestinal urine leakage (16.7%). Furthermore, up to 40% of the sample had an infectious complication 1 month after stent implantation, while the most common cause of failure was persistent hydronephrosis (36.7%). Notably, only two of the 10 ureterointestinal stricture cases and one of the five cases of ureterointestinal urine leakage were resolved with the stent. Furthermore, a statistically significant relationship was found between the indication of the stent and its success: specifically, all cases of poor tolerance to DJ stents and ureteral urine leakage were resolved (OR: 12.66) with the Allium stent.</p><p><strong>Conclusions: </strong>The resolution rate of ureteral pathology with the Allium stent is relatively low. The patients who can benefit the most from this device are those with ureteral urine leakage or poor tolerance to the DJ stent. Among the possible complications, urinary infection in the first month after implantation is the most common.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"3915603251341399"},"PeriodicalIF":0.8,"publicationDate":"2025-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144143676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"\"CLAMP Score\" to predict acute urinary retention in benign prostatic hyperplasia patients.","authors":"Saurav Karmakar, Asim Kumar Das, Tapan Kumar Mandal","doi":"10.1177/03915603251341397","DOIUrl":"https://doi.org/10.1177/03915603251341397","url":null,"abstract":"<p><strong>Introduction: </strong>In men older than 50 years, benign prostatic hyperplasia (BPH) is a common disease and progressive disease. Acute Urinary Retention (AUR) is one of the most common and painful long-term outcomes of BPH. Our study aimed at determining the risk factors which are responsible for developing AUR and formulating a novel scoring system known as \"Retention Score\" or \"CLAMP Score\" to predict the risk of developing AUR in BPH patients in future and manage them in advance.</p><p><strong>Materials and methods: </strong>The present study was a hospital-based comparative study which was conducted at the department of Urology, Nil Ratan Sircar Medical College and Hospital. Two groups were compared one \"with AUR\" and another \"without AUR.\" Various risk factors have been studied including age, international prostate symptom score (IPSS), comorbidities like diabetes mellitus, serum PSA etc. From the study we have formulated and validated a simple out-patient based risk scoring known as \"CLAMP Score\" by which we can stratify the BPH patients into various risk groups of developing AUR.</p><p><strong>Result: </strong>A total of 240 patients has been divided into two groups; 120 in each group. It was found that, majority number of patients with AUR are more than 60 years of age (92.5%) and has comorbidities (84.0%). 68% of these patients has a serum PSA over 1.4 ng/dL and a history of AUR (75%). The mean IPSS was 26.8 and intravesical prostatic projection is more than 12 mm. Our proposed scoring system has a significant association with the patients with AUR group.</p><p><strong>Conclusion: </strong>Our study provides valuable insights into the associations between various risk factors and AUR in BPH patients. Our proposed scoring system will be of great help in predicting AUR in BPH patients on out-patient basis and treat them accordingly in advance.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"3915603251341397"},"PeriodicalIF":0.8,"publicationDate":"2025-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144143670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}